posted on 2024-02-17, 14:05authored byJun-an Zhang, David Haddleton, Paul Wilson, Lin-hua Zhu, Chun-yan Dai, Lin-lu Zhao
Photodynamic therapy (PDT) is a cancer treatment strategy
that
utilizes photosensitizers to convert oxygen within tumors into reactive
singlet oxygen (1O2) to lyse tumor cells. Nevertheless,
pre-existing tumor hypoxia and oxygen consumption during PDT can lead
to an insufficient oxygen supply, potentially reducing the photodynamic
efficacy. In response to this issue, we have devised a pH-responsive
amphiphilic triblock fluorinated polymer (PDP) using copper-mediated
RDRP. This polymer, composed of poly(ethylene glycol) methyl ether
acrylate, 2-(diethylamino)ethyl methacrylate, and (perfluorooctyl)ethyl
acrylate, self-assembles in an aqueous environment. Oxygen, chlorine
e6 (Ce6), and doxorubicin (DOX) can be codelivered efficiently by
PDP. The incorporation of perfluorocarbon into the formulation enhances
the oxygen-carrying capacity of PDP, consequently extending the lifetime
of 1O2. This increased lifetime, in turn, amplifies
the PDT effect and escalates the cellular cytotoxicity. Compared with
PDT alone, PDP@Ce6-DOX-O2 NPs demonstrated significant
inhibition of tumor growth. This study proposes a novel strategy for
enhancing the efficacy of PDT.